Contact Kevin

Speaking Engagements

  

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s conference on Proteomics-Driven Drug Discovery focuses on the use of mass spectrometry, biochemical,

26-27 September 2023
  

Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge Healthtech Institute's Fibrosis and Inflammation conference continues its fifth year of focusing in t

27-28 September 2023